Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Cash Flows

v3.24.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 251,400 $ 311,440 $ 354,108
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, Amortization And Non-Cash Lease Expense 127,052 117,399 115,571
Accounts Receivable, Credit Loss Expense (Reversal) 3,142 (2,044) (10,758)
Gain (Loss) on Disposition of Assets (26,374) (38,194) (1,233)
Deferred income taxes (5,135) (8,118) (9,798)
Share-based Payment Arrangement, Noncash Expense 23,051 21,021 19,126
Changes in operating assets and liabilities:      
Increase (Decrease) in Accounts Receivable 123,830 (64,495) (31,622)
Increase (Decrease) in Inventories 283,826 (399,851) (100,261)
Increase (Decrease) in Prepaid Expense and Other Assets 29,840 (25,749) (24,858)
Increase (Decrease) in Prepaid Expense and Other Assets (29,840) 25,749 24,858
Increase (Decrease) in Other Noncurrent Assets 3,148 2,475 (1,231)
Increase (Decrease) in Accounts Payable (85,862) 40,429 75,513
Increase (Decrease) in Accrued Liabilities (62,239) 20,683 66,457
Increase (Decrease) in Income Taxes Payable (8,800) (5,871) (15,248)
Increase (Decrease) in Other Operating Assets and Liabilities, Net 73,718 62,749 85,176
Increase (Decrease) in Other Noncurrent Liabilities 6,684 (3,055) (1,112)
Net cash provided by operating activities 636,297 (25,241) 354,406
Cash flows from investing activities:      
Payments to Acquire Short-term Investments (528,491) (44,876) (130,191)
Proceeds from Sale, Maturity and Collection of Short-term Investments 121,279 176,083 1,184
Payments to Acquire Productive Assets 54,607 58,467 34,744
Net cash used in investing activities (461,819) 72,740 (163,751)
Cash flows from financing activities:      
Proceeds from Lines of Credit 837 52,918 38,334
Repayments of Lines of Credit (837) (52,979) (38,156)
Payment of line of credit issuance fees 0 (604) 0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 7,354 6,588 28,783
Payment, Tax Withholding, Share-based Payment Arrangement (4,681) (4,229) (5,812)
Payments for Repurchase of Common Stock (184,022) (287,443) (165,415)
Payments of Dividends 73,440 75,082 68,623
Net cash used in financing activities (254,789) (360,831) (210,889)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 389 (19,831) (7,087)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (79,922) (333,163) (27,321)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 430,241 763,404  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 350,319 430,241 763,404
Supplemental disclosures of cash flow information:      
Income Taxes Paid 90,507 92,110 129,483
Supplemental disclosures of non-cash investing activities:      
Capital expenditures incurred but not yet paid 10,125 11,103 5,853
Cash and Cash Equivalents, at Carrying Value $ 350,319 $ 430,241 $ 763,404